"Treatment with dapansutrile, an oral NLRP3 inflammasome inhibitor, was well tolerated and safe over a 14-day treatment period in patients with stable HFrEF" journals.lww.com/cardiovascular…

Thank you Michael Okun for highlighting our case on Agrypnia Excitata, parkinsonism & Anti-Ma2 Ab. x.com/MichaelOkun/st…

Hoy en este día tan especial (29 Feb) hacemos honor a todas esas personas que tienen que convivir a diario con enfermedades poco conocidas y re-conocidas. Poco frecuentes de forma individual pero que afectan a un gran colectivo en su conjunto. #RareDiseaseDay

A new neuroradiological sign in late-onset ataxias: atrophy of cranial nerves V and VIII distinguishes RFC1-related ataxia from MSA and SCAs Kailash Bhatia, Marcelo Merello loom.ly/tgM7fhY

Finally, we are getting closer to solving the challenge of alpha-synuclein aggregates. Our paper in Nature Medicine suggests we have taken an important step. We hope that one day #ParkinsonsDisease will be eliminated. Thanks to all who contributed! nature.com/nm/

Preprint 🚨 This one is important for invasive #Parkinson #neurotech of the future. Deep brain stimulation suppresses oscillatory hyperdirect pathway communication. So does dopamine! Check our #Parkinson study spearheaded by Einstein Center for Neurosciences Berlin #PhD Thomas S. Binns 🧵 biorxiv.org/content/10.110…

El examen MIR no lo es todo, pero es un buen indicador de calidad de nuestros estudiantes. Orgulloso de ser profesor de Facultad de Medicina # Universidad de Navarra Universidad de Navarra Clínica Universidad de Navarra

📣New clinical fellow opportunity working on #parkinsonsdisease research (PPMI) at Centre for Preventive Neurology Wolfson Institute of Population Health with Cristina Simonet, me and the team. qmul-jobs.tal.net/vx/appcentre-e…

Scientists at UCL and Universitätsmedizin Göttingen (UMG), including Dr Jenny Hallqvist, Professor Kevin Mills & Prof Kailash Bhatia, UCL Great Ormond Street Institute of Child Health UCL Queen Square Institute of Neurology have developed a blood test that uses artificial intelligence to predict #Parkinsons up to seven years before the onset of symptoms ucl.ac.uk/news/2024/jun/…

Superb review on the efficacy and safety of GLP1RA by Daniel J Drucker. A must read for all those working in the fields of #obesity #diabetes #overweight diabetesjournals.org/care/article/d…

Today I signed the National Plan to End Parkinson’s Act – a law that will help prevent, treat, and cure Parkinson’s disease and similar disorders. This law is about dignity. It gives people hope that we can end this cruel disease and that we can still do big things.

DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association between the use of GLP-1 agonists and Nonarteritic anterior ischemic optic neuropathy (NAION) jamanetwork.com/journals/jamao… Because of it being heavily promoted by

So proud of this fellow Murcian countryman. Let's hope the best for "LA ROJA " tonight marca.com/tenis/wimbledo…

Can we stimulate brain networks identified using deep brain stimulation from the outside, in a non-invasive fashion? At Center For Brain Circuit Therapeutics, we believe, we can! Our first randomized clinical trial demonstrating this concept is just out in Movement Disorders Journal: doi.org/10.1002/mds.29… A🧵

Really proud of our 400 HIFU treatments at CUN 👇 instagram.com/p/C9zixPLMimq/…

And the results of a small randomized trial vs Alzheimer's disease cnn.com/2024/07/30/hea… by Meg Tirrell —18% slower decline of cognitive function ~50% less brain shrinkage in relevant brain regions

Key Point 1 from the article Autoimmune Movement Disorders by Dr. Bettina Balint from the August Autoimmune Neurology issue, which is available to subscribers at journals.lww.com/continuum/full…. #Neurology #NeuroTwitter #MedEd

El próximo 11 de septiembre: apuntate a la Jornada en Neural Intensive en Madrid: JORNADA EXPERIMENTAL "Una nueva era en neurorrehabilitación: neurología, innovación tecnológica y alto rendimiento al servicio del paciente" inscripcion en el enlace u1h8paiqwo5.typeform.com/to/jQey4M9m